|
|
|
MAPP MAP Pharmaceuticals, Inc. Research
|
Last |
Change |
Change % |
Open |
Volume |
Low |
High |
| MAPP |
24.98 |
0.00 |
0.0% |
0.00 |
0 |
0.00 |
0.00 |
|
|
MAP PHARMACEUTICALS, INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Notice of Delisting us.rd.yahoo.com/.../mapp8-k.html
3/1/13
MAP Pharmaceuticals downgraded to Neutral from Outperform at Wedbush us.rd.yahoo.com/.../...ded-neutral-outperform-175145588.html
3/1/13
Allergan, Inc. Announces Expiration of Tender Offer for All Outstanding Shares of MAP Pharmaceuticals, Inc. and Intent to Exercise Top-Up Option to Effect a Short-Form Merger us.rd.yahoo.com/.../...nces-expiration-tender-140000542.html
3/1/13 [Business Wire] - Allergan, Inc. today announced the expiration of the tender offer initiated by its wholly-owned subsidiary, Groundhog Acquisition, Inc. , on January 31, 2013 to purchase...
Short Interest Jumps 38.3% For MAPP us.rd.yahoo.com/.../?partner=yahootix
2/28/13
Allergan CEOs Pay Jumps by Half With $9 Million Stock Award us.rd.yahoo.com/.../...-half-with-9-million-stock-award.html
2/22/13
|